Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework
- PMID: 19101038
- DOI: 10.1016/j.jad.2008.11.004
Understanding medication non-adherence in bipolar disorders using a Necessity-Concerns Framework
Abstract
Background: Medication non-adherence is a major problem in patients with severe mental disorders and is associated with poor clinical outcomes and high resource utilization. This study examined the utility of the Necessity-Concerns Framework for understanding patient attitudes towards and levels of adherence with medications prescribed for bipolar disorders.
Method: A convenience sample of 223 individuals currently prescribed medication for bipolar disorders, recruited by advertisement in a Manic Depression Fellowship newsletter, completed the Beliefs about Medication Questionnaire and the Medication Adherence Report Scale.
Results: Low adherence was reported by 30% (n=64) and was predicted by greater doubts about personal need for treatment (OR=.50; 95% CI: .31-.82) and stronger concerns about potential negative effects (OR=2.00; 95% CI: 1.20-3.34). These predictors were independent of current mood state, illness and demographic characteristics.
Limitations: Participants were a potentially biased sample of volunteers who had been recruited through a patient organisation newsletter. However, clinical characteristics and adherence rates in this study were similar to those reported in other studies conducted in Europe and the USA.
Conclusions: The Necessity-Concerns Framework is a useful theoretical model for understanding key attitudes towards medication in bipolar disorders. Interventions to facilitate adherence should elicit and address patients' beliefs about medication.
Similar articles
-
Adherence to medication in bipolar disorder: a qualitative study exploring the role of patients' beliefs about the condition and its treatment.Bipolar Disord. 2007 Sep;9(6):656-64. doi: 10.1111/j.1399-5618.2007.00434.x. Bipolar Disord. 2007. PMID: 17845282
-
Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder.J Affect Disord. 2009 Jun;115(3):360-6. doi: 10.1016/j.jad.2008.10.002. Epub 2008 Nov 8. J Affect Disord. 2009. PMID: 18996600 Free PMC article.
-
Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.Schizophr Res. 2011 Oct;132(1):42-9. doi: 10.1016/j.schres.2011.07.019. Epub 2011 Aug 5. Schizophr Res. 2011. PMID: 21820875
-
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8. J Clin Psychiatry. 2009. PMID: 19686636 Review.
-
Enhancing medication adherence in patients with bipolar disorder.Hum Psychopharmacol. 2010 Jan;25(1):1-16. doi: 10.1002/hup.1081. Hum Psychopharmacol. 2010. PMID: 20041478 Review.
Cited by
-
Clinical significance of mobile health assessed sleep duration and variability in bipolar disorder.J Psychiatr Res. 2016 Oct;81:152-9. doi: 10.1016/j.jpsychires.2016.07.008. Epub 2016 Jul 9. J Psychiatr Res. 2016. PMID: 27451108 Free PMC article.
-
Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers.J Neurosci Rural Pract. 2014 Oct;5(4):374-83. doi: 10.4103/0976-3147.139989. J Neurosci Rural Pract. 2014. PMID: 25288840 Free PMC article.
-
Exploring beliefs about heart failure treatment in adherent and nonadherent patients: use of the repertory grid technique.Patient Prefer Adherence. 2013;7:141-50. doi: 10.2147/PPA.S40725. Epub 2013 Feb 18. Patient Prefer Adherence. 2013. PMID: 23550101 Free PMC article.
-
Designing the minimum data set of bipolar disorder: A basis for introducing the effective factors in managing, controlling, and monitoring the bipolar disorder.J Educ Health Promot. 2022 Jun 11;11:147. doi: 10.4103/jehp.jehp_971_21. eCollection 2022. J Educ Health Promot. 2022. PMID: 35847134 Free PMC article.
-
Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative.Int J Bipolar Disord. 2019 Sep 25;7(1):20. doi: 10.1186/s40345-019-0156-x. Int J Bipolar Disord. 2019. PMID: 31552554 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical